U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818252) titled 'Efficacy Evaluation of Turmeric-Derived Nanoparticle Hydrogel for the Treatment of Diabeti... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'PODOMOUNT-Basket, a Phase II, multicentre, randomised, 2 arm parallel-group, double-blind, placeb... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Bepirovirsen Liver Biopsy study'. The following are the other relevant details related to the tri... Read More
U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818785) titled 'The Variation in Electrode Configuration for Termination of Out-of-Hospital Rhythms That A... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitax... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A randomised phase III trial of adjuvant cemiplimab in patients with resected stage IIA-IIIB NSCL... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyro... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus A... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvan... Read More